The European medical cannabis industry is continuing to mature, seeing companies focused on science-based research push the boundaries of our understanding of its use cases, and more importantly, fill the long-maligned gap in clinical evidence.
Cel AI [stock_market_widget type=”chart” template=”line” assets=”CLAI.L” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Cel AI, formely Cellular Goods, has published its interim results as it continues to shift its focus away from its struggling cannabis operations and towards new technologies.
Israeli Cannabis Industry A number of Israel’s leading cannabis companies have issued updates regarding the rapidly evolving situation in the country, which declared war with Hamas last week.
Celadon Pharmaceuticals [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”CEL.L” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] LSE-listed Celadon Pharmaceuticals announced that it had signed a new commercial sales contract set to be worth £1.2m with an unnamed UK pharmaceutical company.
IM Cannabis [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”IMCC” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] International medical cannabis operator IM Cannabis has now received its second warning from NASDAQ regarding its share price, months after pushing through a share price consolidation to remain on the exchange.
Oxford Cannabinoid Technologies [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”OCTP.L” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] Oxford Cannabinoid Technologies announced this week that it had identified a potential ‘first in class’ immunotherapy treatment for solid tumours.
Cantourage [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”HIGH.F” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] German-listed cannabis distributor has seen its stock price jump by around 30% this week on the Frankfurt stock exchange.
InterCure [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”INCR” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] InterCure has continued its blistering run of financial performance after revealing another record quarter over the weekend, ‘solidifying (its) leading position’ over its Israeli competitors and sending its stock up over 20%.
Intercure Israel’s largest cannabis company, Intercure, saw its stock fall around 10% this week as it became involved in a legal dispute with Cann Pharmaceuticals, which trades as Better.
